Psychotropic drugs and adverse kidney effects: a systematic review of the past decade of research

JJ Damba, K Bodenstein, P Lavin, J Drury, H Sekhon… - CNS drugs, 2022 - Springer
Abstract Background and Objective Psychotropic drugs are a heterogenous group of
treatments prescribed for many psychiatric disorders, often for long periods. Their effects on …

Lithium for bipolar disorder: a review of the recent literature

G Curran, A Ravindran - Expert review of neurotherapeutics, 2014 - Taylor & Francis
Lithium is a commonly prescribed treatment for bipolar disorder. Many early studies on
which its use has been historically based no longer meet current research standards. A …

[HTML][HTML] Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data

B Shine, RF McKnight, L Leaver, JR Geddes - The Lancet, 2015 - thelancet.com
Background Lithium is a widely used and highly effective treatment for mood disorders, but
causes poorly characterised adverse effects in kidney and endocrine systems. We aimed to …

Key questions on the long term renal effects of lithium: a review of pertinent data

M Gitlin, M Bauer - International Journal of Bipolar Disorders, 2023 - Springer
For over half a century, it has been widely known that lithium is the most efficacious
maintenance treatment for bipolar disorder. Despite thorough research on the long-term …

[HTML][HTML] One lithium level> 1.0 mmol/L causes an acute decline in eGFR: findings from a retrospective analysis of a monitoring database

E Kirkham, J Skinner, T Anderson, S Bazire… - BMJ open, 2014 - bmjopen.bmj.com
Objectives Lithium is a mainstay of bipolar disorder treatment, however, there are still
differences in opinion on the effects of lithium use on renal function. The aim of this analysis …

The prevention of early-onset neonatal group B streptococcus infection: New Zealand Consensus Guidelines 2014

B Darlow, N Campbell, N Austin, A Chin, C Grigg… - 2015 - researchspace.auckland.ac.nz
AIMS: Group B streptococcal (GBS) disease is the leading cause of early-onset neonatal
sepsis in New Zealand. Disease follows vertical transmission of GBS from the mother, which …

Designing drugs that combat kidney damage

AM Ramos, C Gonzalez-Guerrero, A Sanz… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Kidney disease remains one of the last worldwide frontiers in the field of non-
communicable human disease. From 1990 to 2013, chronic kidney disease (CKD) was the …

Drug information update. Lithium and chronic kidney disease: debates and dilemmas

S Gupta, U Khastgir - BJPsych bulletin, 2017 - cambridge.org
Lithium is an established treatment for bipolar disorder and an augmenting agent for
treatment-resistant depression. Despite awareness of renal adverse effects, including …

Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders

S Rej, D Elie, I Mucsi, KJ Looper, M Segal - Drugs & aging, 2015 - Springer
Lithium is an important medication in the treatment of mood disorders. However, clinicians
are hesitant to use lithium in older adults for fear of its medical effects, particularly kidney …

Lithium use, but not valproate use, is associated with a higher risk of chronic kidney disease in older adults with mental illness

S Rej, N Herrmann, K Shulman… - The Journal of …, 2017 - psychiatrist.com
Objective: Lithium is an essential mood disorder treatment; however, it remains unclear
whether lithium increases chronic kidney disease (CKD) risk. There are few data on this in …